In rats, the oral bioavailbility is about 3.7% and the half-life is 0.80 hours (when given as a PPD-PPT mixture). PPT is unstable in acid, showing 40% degradation after 4 hours at 37°C both in pH 1.2 buffer solution and rat stomach contents.[2] It is extensively metabolized in mice.[3]
^Kang, Soo Yeon; Schini-Kerth, Valérie B.; Kim, Nak Doo (1995). "Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta". Life Sciences. 56 (19): 1577–1586. doi:10.1016/0024-3205(95)00124-o. PMID7723586.
^Kong, LT; Wang, Q; Xiao, BX; Liao, YH; He, XX; Ye, LH; Liu, XM; Chang, Q (April 2013). "Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats". Fitoterapia. 86: 48–53. doi:10.1016/j.fitote.2013.01.019. PMID23391424.
^Wang, YZ; Wang, YS; Chu, SF; Chen, NH; Zhang, JT (April 2010). "Protopanaxatriol metabolites identified by LC-MS/MS after oral administration in mice". International journal of clinical pharmacology and therapeutics. 48 (4): 282–90. doi:10.5414/cpp48282. PMID20353750.